Delayed
Toronto S.E.
09:52:05 2024-05-13 am EDT
|
5-day change
|
1st Jan Change
|
14.82
CAD
|
-2.11%
|
|
+4.66%
|
+28.98%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
1,218
|
947.9
|
1,008
|
795
|
838.4
|
1,105
|
-
|
Enterprise Value (EV)
1 |
1,218
|
947.9
|
1,008
|
795
|
838.4
|
1,105
|
1,105
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
5.07%
|
6.62%
|
6.23%
|
8.59%
|
8.15%
|
6.21%
|
6.21%
|
Capitalization / Revenue
|
1.82
x
|
1.43
x
|
1.51
x
|
1.11
x
|
1.07
x
|
1.3
x
|
1.29
x
|
EV / Revenue
|
1.82
x
|
1.43
x
|
1.51
x
|
1.11
x
|
1.07
x
|
1.3
x
|
1.29
x
|
EV / EBITDA
|
9.22
x
|
10.3
x
|
9.09
x
|
6.72
x
|
6.6
x
|
6.94
x
|
8.11
x
|
EV / FCF
|
18.3
x
|
18.9
x
|
17.3
x
|
15.8
x
|
12.9
x
|
184
x
|
158
x
|
FCF Yield
|
5.47%
|
5.28%
|
5.78%
|
6.34%
|
7.74%
|
0.54%
|
0.63%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
66,713
|
67,039
|
67,039
|
72,940
|
72,967
|
72,967
|
-
|
Reference price
2 |
18.26
|
14.14
|
15.03
|
10.90
|
11.49
|
15.14
|
15.14
|
Announcement Date
|
2/19/20
|
2/18/21
|
2/24/22
|
2/23/23
|
2/20/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
669.7
|
664.2
|
668.5
|
718.6
|
785.4
|
851
|
858
|
EBITDA
1 |
132.1
|
91.96
|
110.8
|
118.2
|
127
|
159.1
|
136.3
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
66.61
|
50.07
|
58.22
|
50.44
|
64.92
|
6
|
7
|
FCF margin
|
9.95%
|
7.54%
|
8.71%
|
7.02%
|
8.27%
|
0.71%
|
0.82%
|
FCF Conversion (EBITDA)
|
50.44%
|
54.45%
|
52.53%
|
42.65%
|
51.13%
|
3.77%
|
5.14%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.9255
|
0.9360
|
0.9360
|
0.9360
|
0.9360
|
0.9400
|
0.9400
|
Announcement Date
|
2/19/20
|
2/18/21
|
2/24/22
|
2/23/23
|
2/20/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-
|
-
|
35.2
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2340
|
0.2300
|
0.2300
|
0.2300
|
0.2300
|
Announcement Date
|
2/24/22
|
5/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
66.6
|
50.1
|
58.2
|
50.4
|
64.9
|
6
|
7
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/19/20
|
2/18/21
|
2/24/22
|
2/23/23
|
2/20/24
|
-
|
-
|
Last Close Price
15.14
CAD Average target price
15.29
CAD Spread / Average Target +0.96% Consensus |
1st Jan change
|
Capi.
|
---|
| +31.77% | 809M | | -17.59% | 2.39B | | +2.74% | 1.46B | | -27.62% | 1.43B | | +21.31% | 1.36B | | -10.00% | 435M | | +234.05% | 424M | | -3.59% | 344M | | +9.41% | 136M | | +46.62% | 95.83M |
Residential & Long-Term Care
|